Gangwar S, Jois S D, Siahaan T J, Vander Velde D G, Stella V J, Borchardt R T
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence 66047, USA.
Pharm Res. 1996 Nov;13(11):1657-62. doi: 10.1023/a:1016484522113.
To determine the different conformations of the acyloxyalkoxy-linked cyclic prodrug 1 of the model hexapeptide 2 in solution and to investigate the relationship between these solution conformations and the cellular permeability characteristics of this prodrug.
Two-dimensional Homonuclear Hartmann-Hahn spectroscopy, Rotating-Frame Overhouser effect spectroscopy, circular dichroism and molecular dynamics simulations were used to find the solution conformers of cyclic prodrug 1.
Our spectroscopic findings suggest that cyclic prodrug 1 exhibits a major and a minor conformer in solution. The major conformer appears to have a well-defined secondary structure, which involves a beta-turn and 4-->1 intramolecular hydrogen bond, creating a compact structure with a reduced average hydrodynamic radius compared to the model hexapeptide 2.
The increased ability of cyclic prodrug 1 to permeate membranes compared to the model hexapeptide 2 could be due to reduction in the average hydrodynamic radius of the molecule facilitating paracellular flux and/or the reduction in the hydrogen bonding potential facilitating transcellular flux.
确定模型六肽2的酰氧基烷氧基连接的环前药1在溶液中的不同构象,并研究这些溶液构象与该前药的细胞渗透特性之间的关系。
使用二维同核Hartmann-Hahn光谱、旋转框架Overhouser效应光谱、圆二色性和分子动力学模拟来寻找环前药1的溶液构象异构体。
我们的光谱研究结果表明,环前药1在溶液中呈现出一种主要构象异构体和一种次要构象异构体。主要构象异构体似乎具有明确的二级结构,其中涉及一个β-转角和4→1分子内氢键,形成了一种紧凑结构,与模型六肽2相比,其平均流体力学半径减小。
与模型六肽2相比,环前药1透过膜的能力增强可能是由于分子平均流体力学半径减小促进了细胞旁通量和/或氢键潜力降低促进了跨细胞通量。